Packaging Pharmaceutical Companies White Paper 
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. While using high-capacity aircraft and minimal packaging reduces weight and increases capacity for vital products by using fewer flights.
Pharmaceutical Technology
JUNE 24, 2025
This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. DMC’s innovative design incorporates an ultrathin conductive layer, typically made of gold, which enables the application of electrical fields across ionic and affinity membrane adsorbers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 6, 2025
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. We need to fundamentally change that so that we are focusing on curing disease and making people better.”
Pharmaceutical Technology
JUNE 19, 2025
Large pharmaceutical companies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51
Pharmaceutical Technology
JUNE 25, 2025
By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceutical companies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Stay proactive with real-time data and expert analysis.
Pharmaceutical Technology
JUNE 25, 2025
Other countries from outside the EU and international organisations such as pharmaceutical companies will be able to apply to join HealthData@EU for secondary use in March 2034. In March 2031, secondary use data will be made available, including medical images, lab results, and hospital discharge reports.
Pharmaceutical Technology
JUNE 25, 2025
Vaccine R&D stagnation likely Although ACIP recommendations are separate from the US Food and Drug Administration (FDA)’s approvals, national immunisation recommendation provides a key pillar on which to guide pipeline development for a pharmaceutical company. Give your business an edge with our leading industry insights.
Expert insights. Personalized for you.
142 
Let's personalize your content